Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Nano-Drugs Based on Nano Sterically Stabilized Liposomes for the Treatment of Inflammatory Neurodegenerative Diseases.
Job placement interventions for people with multiple sclerosis.
Present and emerging therapies for multiple sclerosis.
The Roles of Vitamin D and Its Analogs in Inflammatory Diseases.
Natural Killer Cell Subsets in Cerebrospinal Fluid of Patients with Multiple Sclerosis.
Screening for inhibitors of microglia to reduce neuroinflammation.
Detection of intrathecal immunoglobulin G synthesis by capillary isoelectric focusing immunoassay in oligoclonal band negative multiple sclerosis.
Ontogeny and Functions of Central Nervous System Macrophages.
Complement activation and expression during chronic relapsing experimental autoimmune encephalomyelitis in the Biozzi ABH mouse.
Urodynamic changes in mice with experimental autoimmune encephalomyelitis correlate with neurological impairment.
Stress, Multiple Sclerosis, and Everyday FunctioningA Review of the Literature with Implications for Intervention.
Circulating MicroRNAs: A Novel Class of Potential Biomarkers for Diagnosing and Prognosing Central Nervous System Diseases.
Serum Arsenic and Lipid Peroxidation Levels in Patients with Multiple Sclerosis.
Clinical neurophysiology of multiple sclerosis.
A unified cell biological perspective on axon-myelin injury.
Neuroinflammation and M2 microglia: the good, the bad, and the inflamed.
Modulating neurotoxicity through CX3CL1/CX3CR1 signaling.
Novel advances in the diagnosis and treatment of neuromyelitis optica: is there a need to redefine the gold standard?
TLR4-activated microglia require IFN-γ to induce severe neuronal dysfunction and death in situ.
[Characteristics of coping strategies in patients with multiple sclerosis(review)].
Restless legs syndrome in Iranian multiple sclerosis patients: a case-control study.
Correction: An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response.
Cytoplasmic sphingosine-1-phosphate pathway modulates neuronal autophagy.
Differential efficacy of the TSPO ligands etifoxine and XBD-173 in two rodent models of Multiple Sclerosis.
Protein array-based profiling of CSF identifies RBPJ as an autoantigen in multiple sclerosis.

Pages